Apollo Hospitals Unveils New Clinical Initiatives in Colorectal Surgery at the 5th Edition of Apollo International Colorectal Surgery Symposium

0
338
Prof. Dr Emre Gorgun, Vice Chairman - Department of Colorectal Surgery, Cleveland Clinic Florida, USA, Prof. Manish Chand, Consultant Colorectal Surgeon and Associate Professor University College London, UK, Prof Steven D Wexner, Director, Digestive Disease Center & Chairman- Dept of Colorectal Surgery, Cleveland Clinic Florida, USA, Dr Preetha Reddy, Executive Vice Chairperson Apollo Hospitals Enterprise Ltd, Mr Harshad Reddy, Director- Group Oncology & International, Apollo Hospitals, Prof Venkatesh Munikrishnan, Consultant, Colorectal Surgeon & Clinical Lead Institute of Colorectal Surgery, Apollo Hospitals, Dr Madhu Sashidhar, President & CEO, Apollo Hospitals were launching the ARC 360 degree, India's first multidisciplinary rectal cancer training program today at Apollo Proton Cancer Centre, Chennai.

Chennai, August 30, 2024: – Apollo Hospitals, a leader in healthcare innovation,
unveiled the new groundbreaking clinical initiatives in colorectal surgery, during the
inauguration of the 5 th edition of Apollo International Colorectal Surgery Symposium
(AICRS 2024). The event also marks the release of the latest patient clinical
outcomes from the Apollo Rectal Cancer Programme.

Apollo Hospitals, a pioneer in the field of advanced colorectal healthcare, is set to transform the landscape of colorectal surgery with the introduction of innovative clinical initiatives. These initiatives are designed to enhance surgical precision, improve patient outcomes, and streamline care processes, solidifying Apollo’s position as a global leader in colorectal healthcare.

The Apollo Proton Cancer Centre’s / Apollo Hospitals ARC Programme has achieved
outstanding clinical outcomes in Rectal Cancer Surgery, surpassing global standards in
key areas. Notably, the programme has reported a lower resection margin positivity rate of 4.6% compared to the global standard of 5.2%, anastomotic leak rates of 0.9% versus 2.6%, wound infection rates of 1.4% versus 5.2%, and readmission rates of 1.9% versus 21.4%. Additionally, the programme has seen a significant reduction in robotic to open conversion rates, at 1% compared to 7.0%. These exceptional outcomes have also led to improved survival rates, with significant advancements in treatment protocols contributing to higher long-term survival rates for rectal cancer patients.

Prof Dr Venkatesh Munikrishnan, Consultant, Colorectal Surgeon & Clinical Lead Institute of Colorectal Surgery, Apollo Hospitals, said, “The 5th Apollo International Colorectal Surgery Symposium, is a landmark event that is poised to revolutionize colorectal cancer care. We have standardized robotic surgeries and built the world’s most cost- efficient robotic surgery programme for colorectal cancer. On an average we are at ¼th cost of a similar procedure in western countries. Apollo Proton’s ARC
Programme has been a game-changer in rectal cancer treatment, where we’ve seen
remarkable outcomes, enhancing patients’ quality of life.”

New Initiatives In Colorectal Surgery: Key Highlights

Expanding the Robotic Surgery Programme: Apollo Hospitals is expanding its state-of-the-art robotic-assisted surgery programme across India. This expansion, aims to reduce recovery times, increase surgical accuracy, and make advanced surgical care accessible to more patients.

Apollo Rectal Cancer (ARC) Programme & Mthe ARC 360 degree: The Apollo Rectal Cancer (ARC) Programme, presented by Apollo Proton Cancer Centre, is a comprehensive initiative that integrates a team of specialists dedicated to providing holistic care—from diagnosis through post-surgical support. As part of this initiative, the ARC360 degree programme will train clinical teams from around the world to achieve world- class outcomes in rectal cancer care, reflecting Apollo’s commitment to global healthcare excellence

Apollo Robotic Colorectal Surgery Fellowship: Apollo Hospitals is launching a new
one-year robotic colorectal surgery fellowship for postgraduate surgeons. This programme will equip the next generation of surgeons with the skills and expertise needed to excel in the rapidly evolving field of robotic surgery.

Prof Dr Steven D Wexner, Director, Digestive Disease Center & Chairman- Dept of Colorectal Surgery, Cleveland Clinic Florida, USA, said, “The opportunity for
colorectal surgeons to work among three of the world’s leading departments, located
in North America, Asia, and Europe, is truly unique. Over the past decade, Dr.
Munikrishnan, Dr. Chand and I, have engaged in unparalleled collaboration, sharing
best practices, enriching educational experiences, and advancing technological
innovations. These efforts have led to continuous optimization of patient outcomes.
The willingness of these surgeons to generously share their knowledge
internationally, both in person through podium presentations and in press and journal
publications, has ensured that their collaborative advances benefit patients
worldwide.”

Dr Preetha Reddy Executive Vice Chairperson Apollo Hospitals Enterprise Ltd,
said, “The Apollo International Colorectal Surgery Symposium stands as a premier
global event, bringing together the world’s most distinguished experts, researchers,
and clinicians in colorectal surgery. This ground-breaking symposium is not just a
gathering of minds; it is a transformative learning experience, especially for young
surgeons. In an unprecedented move in India, we have made registration
complimentary, ensuring that emerging talent has unhindered access to this wealth
of knowledge. Our ARC Programme has consistently delivered exceptional clinical
outcomes, surpassing global benchmarks in several critical areas. We are privileged
to showcase these achievements at the 5th Apollo International Colorectal Surgery
Symposium, further reinforcing our commitment to advancing healthcare.”